Tumor heterogeneity and chemosensitivity to cyclophosphamide, vinblastine and hexadecylphosphocholine.
Angres
G
G
Universitäts-Hals-Nasen-Ohrenklinik, Heidelberg, F.R.G.
Scherf
H R
HR
Schmähl
D
D
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002999:Clone Cells; D003520:Cyclophosphamide / Q000627:therapeutic use*; D004354:Drug Screening Assays, Antitumor; D005260:Female; D006801:Humans; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy* / Q000473:pathology; D010767:Phosphorylcholine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D051381:Rats; D011919:Rats, Inbred Strains; D014407:Tumor Cells, Cultured / Q000187:drug effects / Q000473:pathology; D014747:Vinblastine / Q000494:pharmacology*
D000970:Antineoplastic Agents; D010767:Phosphorylcholine; C039128:miltefosine; D014747:Vinblastine; D003520:Cyclophosphamide